Compare ZEPP & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZEPP | FBRX |
|---|---|---|
| Founded | 2013 | N/A |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Computer Manufacturing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 327.7M | 367.4M |
| IPO Year | N/A | N/A |
| Metric | ZEPP | FBRX |
|---|---|---|
| Price | $16.86 | $32.10 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $67.00 |
| AVG Volume (30 Days) | 132.4K | ★ 247.9K |
| Earning Date | 11-04-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $233,274,000.00 | N/A |
| Revenue This Year | $887.39 | N/A |
| Revenue Next Year | $26.12 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 11.64 | N/A |
| 52 Week Low | $2.13 | $4.90 |
| 52 Week High | $61.85 | $35.62 |
| Indicator | ZEPP | FBRX |
|---|---|---|
| Relative Strength Index (RSI) | 27.66 | 55.14 |
| Support Level | $15.37 | $26.66 |
| Resistance Level | $24.80 | $35.50 |
| Average True Range (ATR) | 1.84 | 3.40 |
| MACD | -0.49 | -0.19 |
| Stochastic Oscillator | 17.39 | 59.32 |
Zepp Health Corp is engaged in the business of manufacturing smart health wearable products. The company operates in one segment which is Amazfit-branded products. The product portfolio includes smartwatches and fitness bands.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).